| NATURE OF OPERATIONS AND BASIS OF PRESENTATION |
NOTE 1. NATURE OF OPERATIONS
AND BASIS OF PRESENTATION
Longduoduo Company Limited (“Longduoduo”,
together as a group with Longduoduo’s subsidiaries referred to as the “Company” or “we”) was incorporated
in the State of Nevada on October 25, 2021. Acting in a principal capacity, the Company provides customers comprehensive and high-quality
preventive healthcare solutions including a wide range of preventive healthcare services, including disease screening healthcare treatment,
healthcare products and other services through a network of third-party healthcare service providers. In June 2023, the Company began
to engage in agent sales of preventive healthcare solutions on behalf of a third-party provider and earn commissions revenue.
On September 21, 2023, the Company implemented
a 1-for-10 reverse split of its outstanding common stock, effective at the close of business on September 26, 2023. The accompanying financial
statements have been adjusted to retroactively reflect this reverse stock split.
Longduoduo’s subsidiaries include:
| | ● | Longduoduo Company Limited (Hong Kong) (“Longduoduo HK”), which was established on July 26, 2021 under the laws of Hong Kong. On October 26, 2021, Longduoduo issued 30,000,000 shares of its common stock to the original shareholders of Longduoduo HK, in exchange for 100% of the outstanding shares of Longduoduo HK. |
| | ● | LDD Technology Limited (“LDD”) was established on March 18, 2024 under the laws of British Virgin Islands. On February 19, 2025, Longduoduo issued 10,020 shares of its common stock to the original shareholders of LDD, in exchange for 100% of the outstanding shares of LDD. |
| | ● | LDDJK Hong Kong Limited (“LDDJK”) was established on April 9, 2024 under the laws of Hong Kong. LDD has controlled 100% of LDDJK since its inception. |
| | ● | Beijing Julong Health Consulting Co., Limited (“Julong”) was established in Beijing, China on July 23, 2024. LDDJK has controlled 100% of Julong since its inception. |
| | ● | Beijing Yihua Health Consulting Co., Limited (“Yihua”) was established in Beijing, China on March 14, 2024. On January 7, 2025, Julong acquired all the shares held by the original shareholders of Yihua, and controlled 100% ownership of Yihua. |
| | ● | Longduoduo Health Technology Company Limited (“Longduoduo Health Technology”), a privately held Limited Company registered in Inner Mongolia, China on August 20, 2020. On August 16, 2021, Longduoduo HK acquired 100% of the ownership of Longduoduo Health Technology from the original shareholders of Longduoduo Health Technology. On April 2, 2025, Julong acquired 100% of Longduoduo Health Technology from Longduoduo HK. |
| | ● | Inner Mongolia Qingguo Health Consulting Company Limited (“Qingguo”), a privately held Limited Company registered in Inner Mongolia, China on June 18, 2020. On September 8, 2020, Longduoduo Health Technology acquired 90% of the ownership of Qingguo from the original shareholders of Qingguo. |
| | ● | Inner Mongolia Rongbin Health Consulting Company Limited (“Rongbin”), a privately held Limited Company, registered in Inner Mongolia, China on March 18, 2021. Longduoduo Health Technology has controlled 80% of the ownership of Rongbin since established. |
| | ● | Inner Mongolia Chengheng Health Consulting Company Limited (“Chengheng”), a privately held Limited Company, registered in Inner Mongolia, China on April 9, 2021. Longduoduo Health Technology has controlled 80% of the ownership of Chengheng since established. |
| | ● | Inner Mongolia Tianju Health Consulting Company Limited (“Tianju”), a privately held Limited Company, registered in Inner Mongolia, China on July 5, 2021. Longduoduo Health Technology has controlled 51% of Tianju since inception. |
The transactions summarized above are treated
in the Company’s financial statements as a corporate restructuring (reorganization) of entities under common control, as each of
the eleven entities have at all times been under the control of Mr. Zhang Liang. Therefore, in accordance with ASC 805-50-45-5, the current
capital structure has been retroactively presented in prior periods as if such structure existed at that time, and the entities under
common control are presented on a combined basis for all periods. Since all of the subsidiaries were under common control for all periods
presented, the results of these subsidiaries are included in the Company’s financial statements for all periods presented.
|